COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
Health care facilities or providers facing inadequate supplies of certain drugs needed to treat patients with COVID-19 should not use the products more than four hours beyond the labeled 鈥渋n-use time鈥 for refrigerated storage or two hours beyond the labeled 鈥渋n-use time鈥 for room temperature鈥
The National Institutes of Health announced clinical trials to investigate the safety and efficacy of a synthetic antibody therapy in COVID-19 patients.
The Centers for Medicare & Medicaid Services will allow health insurers to offer premium reductions for individuals with 2020 coverage in the individual and small group markets when consistent with state law, the agency announced.
The 黑料正能量 Association (AHA) urges the Centers for Medicare & Medicaid Services (CMS) to allow periodic interim payment (PIP) hospitals to carry out their accelerated payment repayment at cost settlement, as was initially communicated by the agency. We also request that the agency鈥
The Department of Health and Human Services updated its guidance and FAQs regarding the agency鈥檚 request for daily COVID-19-related hospital data reporting.
The Centers for Disease Control and Prevention Aug. 3 at 3 p.m. ET will hold a webinar with updates on the COVID-19 response, including new resources for businesses and other private-sector organizations.
A study released by the Centers for Disease Control and Prevention demonstrates that SARS-CoV-2 spreads efficiently in youth-centric settings, resulting in high attack rates among persons in all age groups.
The Food and Drug Administration updated its FAQs on the emergency use authorization of remdesivir for use on certain hospitalized COVID-19 patients. The document includes information on the changes to Gilead鈥檚 fact sheets for health care providers and patient caregivers.
The Centers for Medicare & Medicaid Services added 12 new ICD-10 procedure codes to identify new therapies for COVID-19.
The Centers for Disease Control and Prevention Aug. 4 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on telehealth鈥檚 benefits and challenges, based on lessons learned during the COVID-19 pandemic.